AKT1 and cancer: Embelin was found to inhibit the binding of XIAP (an anti-apoptotic protein) to the initiation caspase, thereby producing cytotoxic effects by reducing the activity of various signaling pathways, mainly PI3Kinase/AKT pathway in different cancer cells (Prabhu et al., 2017[59]).